ProCE Banner Activity

What I Want My Colleagues to Know About Ki67 in HR-Positive/HER2-Negative Early Breast Cancer

Clinical Thought
Are you testing for Ki67 expression levels in patients with early-stage hormone receptor-positive/HER2-negative breast cancer? Read this commentary for a pathologist’s perspective on Ki67 testing.

Released: December 28, 2021

Expiration: December 27, 2022

No longer available for credit.
Begin Activity



Sunil Badve

Sunil Badve, MD, FRCPath

Provided by

Provided by a partnership between the American Society for Clinical Pathology and Clinical Care Options, LLC.
ProCE Banner


This activity is supported by an educational grant from


Faculty Disclosure

Primary Author

Sunil Badve, MD, FRCPath